Groups: Investment

Beau Bassett

Beau is Head of Therapeutics at Pura Vida, where he leads idea generation for the therapeutics subsectors and works with Efrem Kamen on risk management decisions for the therapeutics subsectors. Prior to re-joining the firm in 2017, Beau was the Senior Analyst for the drug portfolio at Passaic, the largest healthcare dedicated pod at Millennium, …

Beau Bassett Read More »

Frank Litvack, MD

Frank is a co-founder of Pura Vida Investments and serves as Member, Director of Designated Investments. Frank has an extensive background in healthcare ranging from clinical practice and research to founding and operating companies. He currently serves as CEO of Vida FLaSH Acquisitions, Inc., a life sciences SPAC as well as co-managing member of FLaSH …

Frank Litvack, MD Read More »

Efrem Kamen

Efrem is a founder and Managing Member at Pura Vida, directing the company’s investments across the healthcare universe spanning medical technology, biotechnology, and other emerging areas of healthcare and consumer products. He is currently an Adjunct Associate Professor at Columbia Business School, where he created and teaches a course on investing in medical technology, and …

Efrem Kamen Read More »

Scroll to Top